Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02AOD
|
||||
Former ID |
DIB003651
|
||||
Drug Name |
HF-0220
|
||||
Synonyms |
Cytoprotective steroid (Alzheimer's disease), Newron; Prostaglandin D synthase stimulator (Alzheimer's disease), Newron; Prostaglandin J2 synthesis stimulator (Alzheimer's disease), Newron; Cytoprotective steroid (Alzheimer's disease), Hunter-Fleming; Prostaglandin D synthase stimulator (Alzheimer's disease), Hunter-Fleming; Prostaglandin J2 synthesis stimulator (Alzheimer's disease), Hunter-Fleming
|
||||
Indication | Alzheimer disease [ICD9: 331; ICD10:G30] | Phase 2 | [521861] | ||
Company |
Hunter-Fleming Ltd
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
[C@H]12[C@H]([C@H]3[C@](CC2)(C(=O)CC3)C)[C@H](C[C@@H]2[<br />C@@]1(CC[C@@H](C2)O)C)O
|
||||
Target and Pathway | |||||
Target(s) | Glutathione S-transferase | Target Info | Stimulator | [550953] | |
BioCyc Pathway | C20 prostanoid biosynthesis | ||||
KEGG Pathway | Arachidonic acid metabolism | ||||
Metabolic pathways | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.